Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3

NCT: NCT07743866 · NOT_YET_RECRUITING

NCT IDNCT07743866
StatusNOT_YET_RECRUITING
Start Date2026-08-07
Completion2027-02-28
SponsorFirst Affiliated Hospital of Fujian Medical University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this research study is to identify the optimal biological dose for tTIS that targets DN in SCA3 while achieving the best possible balance between therapeutic efficacy and safety.

Frequently Asked Questions

What is Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3?

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3 is a clinical trial registered under NCT07743866. Current status: NOT_YET_RECRUITING.

What is the status of NCT07743866?

The current status of NCT07743866 (Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3) is: NOT_YET_RECRUITING.

When did Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3 start?

Optimizing Parameters of Transcranial Temporal Interference Stimulation for Spinocerebellar Ataxia Type 3 started on 2026-08-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑